| Systematic (IUPAC) name | |
|---|---|
| 2-[(1-{2-[2-(2-{2-[2-(2-amino-3-carbamoylpropanamido)-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido}-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido]-3-(1H-imidazol-5-yl)propanoyl}pyrrolidin-2-yl)formamido]-3-phenylpropanoic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Intravenous infusion |
| Identifiers | |
| CAS number | 53-73-6 |
| ATC code | C01CX06 |
| PubChem | CID 10351092 |
| ChemSpider | 8526544 |
| UNII | 7WAL1X78KV |
| KEGG | D02939 |
| ChEMBL | CHEMBL409803 |
| Chemical data | |
| Formula | C49H70N14O11 |
| Mol. mass | 1031.17 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Angiotensinamide (INN; BAN and USAN angiotensin amide) is a potent vasoconstrictor used as a cardiac stimulant. It is a derivative of angiotensin II.
|
|||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)